Follow last change Nov 2008 re-read 3 minutes ago

116E

Developed for: diarrheal disease · Rotavirus infection
Investigated by: Centers for Disease Control and Prevention · Ministry of Science and Technology, India · National Institutes of Health (NIH) · PATH · Stanford University · All India Institute of Medical Sciences
+5 more
· Bharat Biotech International Limited · Children's Hospital Medical Center, Cincinnati · Indian Council of Medical Research · Indian Institute of Science · Society for Applied Studies

today NCT00439660 · Ph 1/2 NCT00280111 · Ph 1

20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 11 trial
Phase 1	NCT00280111	Jan → May 2005	Rotavirus infection	Society for Applied Studies	Completed	No outcome recorded
Phase 1/21 trial
Phase 1/2	NCT00439660	Dec 2006 → Nov 2008	diarrheal disease	Bharat Biotech International Limited	Completed	No outcome recorded

Every value below carries the sentence it was read from. 2 sources stand behind the page.

Field	Value	Cited text
Known as	116E	ClinicalTrials.gov intervention name — accepted as the source's own label NCT00439660 ↗ 1 NCT00280111 ↗
Modality	Vaccine	“live attenuated neonatal rotavirus vaccine candidate strains 116E or I321” NCT00280111 ↗